| Literature DB >> 34532537 |
Joseph McInnes1,2,3, Lujia Zhou1,2, And Patrik Verstreken1,2.
Abstract
Dysfunction of the microtubule-associated protein Tau (encoded by the MAPT gene) has been implicated in more than twenty neurodegenerative diseases, including Alzheimer's. As such, the physiological and disease-relevant functions of Tau have garnered great interest in the research community. One barrier hampering investigations into the functions of Tau and the generation of pharmacological agents targeting Tau has been the difficulty of obtaining soluble Tau protein in purified form. Here, we describe a protocol that uses dual affinity tag purification to selectively purify soluble recombinant Tau protein from bacteria that is functionally active for downstream applications including immunization, microtubule binding assays, and protein-protein interaction studies.Entities:
Keywords: Alzheimer’s; MAPT; Protein purification; Recombinant Tau; Soluble Tau; Tau
Year: 2018 PMID: 34532537 PMCID: PMC8342052 DOI: 10.21769/BioProtoc.3043
Source DB: PubMed Journal: Bio Protoc ISSN: 2331-8325